Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NOEMI D CABRERA

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1558872986
CMS profile
10801154
Location
LAS VEGAS, NV

General Payments · PY2021–2024

$7,497.18

  • Reported across 299 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$476.18

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $476.18 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $318.23 9
Abbott Laboratories $44.83 2
Astellas Pharma US Inc $44.74 2
Amgen Inc. $29.29 1
Novo Nordisk AS $21.67 1
Lilly USA, LLC $17.42 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $1,193.57 55
PY2022 $3,361.44 118
PY2023 $2,465.99 110
PY2024 $476.18 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $16.99 02/23/2024 Food and Beverage Undisputed 01/23/2026 1125126417 CMS
Abbott Laboratories $27.84 03/27/2024 Food and Beverage Undisputed 01/23/2026 1125126419 CMS
ABBVIE INC. $29.31 01/17/2024 Food and Beverage Undisputed 01/23/2026 1106861091 CMS
ABBVIE INC. $24.23 02/28/2024 Food and Beverage Undisputed 01/23/2026 1106861093 CMS
ABBVIE INC. $21.16 04/18/2024 Food and Beverage Undisputed 01/23/2026 1106861095 CMS
ABBVIE INC. $123.55 04/25/2024 Food and Beverage Undisputed 01/23/2026 1106861097 CMS
ABBVIE INC. $22.85 05/07/2024 Food and Beverage Undisputed 01/23/2026 1106861099 CMS
ABBVIE INC. $31.16 05/08/2024 Food and Beverage Undisputed 01/23/2026 1106861101 CMS
ABBVIE INC. $25.58 07/31/2024 Food and Beverage Undisputed 01/23/2026 1106861103 CMS
ABBVIE INC. $12.45 09/04/2024 Food and Beverage Undisputed 01/23/2026 1106861105 CMS
ABBVIE INC. $27.94 10/23/2024 Food and Beverage Undisputed 01/23/2026 1106861107 CMS
Amgen Inc. $29.29 04/22/2024 Food and Beverage Undisputed 01/23/2026 1117518657 CMS
Astellas Pharma US Inc $23.43 02/20/2024 Food and Beverage Undisputed 01/23/2026 1139481162 CMS
Astellas Pharma US Inc $21.31 08/28/2024 Food and Beverage Undisputed 01/23/2026 1139534680 CMS
Lilly USA, LLC $17.42 02/06/2024 Food and Beverage Undisputed 01/23/2026 1135937606 CMS
Novo Nordisk Inc $21.67 05/02/2024 Food and Beverage Undisputed 01/23/2026 1100338093 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.